US Drug Policy & Opioid Crisis
Emerging drug threats, regulatory responses, and public health initiatives addressing substance abuse epidemics and novel psychoactive substances in the United States.
5 events tracked
Latest in US Drug Policy & Opioid Crisis· Oct 19
American churches are now operating as frontline addiction services as xylazine, a veterinary sedative mixed into illicit opioids, reshapes the drug crisis beyond traditional healthcare capacity. The shift exposes gaps in formal treatment infrastructure and is driving demand for mental health and addiction services that existing systems cannot meet. Religious institutions filling this void signals that the opioid crisis has expanded into a broader synthetic drug problem requiring infrastructure investment outside conventional medical channels.
- Single source3 days ago
American churches combat xylazine as synthetic opioids reshape drug crisis
US churches are confronting xylazine addiction as the opioid crisis evolves, raising demand for community-based intervention.
BBC News
- Single source4 days ago
Chicago fights surging synthetic drug crisis on South Side streets
Chicago confronts a surge in synthetic drug use, straining public health and law enforcement resources.
BBC News
- Single source5 days ago
Homemade synthetic drugs proliferate across United States, worsening addiction crisis
Homemade synthetic drugs proliferate across the US, intensifying the addiction crisis.
BBC News
- Single source10 days ago
States face decisions on allocating Meta settlement funds
States must decide how to allocate billions from Meta settlement, raising questions about spending priorities and regulatory enforcement outcomes.
The New York Times
- Single source27 days ago
US government officials warn about kratom sold at convenience stores
US officials express alarm over kratom, a plant-derived substance marketed at gas stations, citing addiction and health concerns.
BBC News